Novartis AG
1,4-DISUBSTITUTED PYRIDAZINE ANALOGS THERE OF AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS

Last updated:

Abstract:

The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof; ##STR00001## a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

Status:
Application
Type:

Utility

Filling date:

2 Jan 2019

Issue date:

28 Nov 2019